ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2020

Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model.

Noha H Sayed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.